N/A
N=171
Web and Shared Decision Making for Reserve/National Guard Women's PTSD Care
PTSD
Bottom Line
View on ClinicalTrials.gov: NCT01710306 ↗Enrolled (actual)
171
Serious AEs
0.0%
Results posted
Feb 2019
Primary outcome: Primary: Number of Participants With VA Mental Health Care Engagement — 40; 30; 28; 28 Participants — p=0.1996
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Nurse Care Manager (NCM) (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- VA Office of Research and Development
- Primary completion
- Mar 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With VA Mental Health Care Engagement |
40; 30; 28; 28; 18; 27 | 0.1996 |
| SECONDARY Patient Activation Measure |
50; 53 | — |
Summary
Women and Reserve/National (RNG) Veterans are among the fastest growing groups of new VA users. While PTSD is prevalent in this group, most women don't access or complete needed treatment. This study will investigate Operation enduring/Iraqi Freedom and New Dawn (OEF/OIF/OND) RNG female war Veterans' perceptions, preferences, barriers and facilitators to accessing VA mental health (MH) and evidence-based PTSD psychotherapy. This information will be used to revise an existing web-based screen that educates participants about their unique post-deployment MH conditions. This web-interface will then be used to randomly assign women who screen positive for PTSD to either 1) a concierge nurse case manager who uses shared decision-making to engage Veterans in EBP or 2) usual outreach to determine what engagement approach women prefer. The investigators' findings will provide VA leaders with key information to understand and improve access to RNG PTSD treatment.
Eligibility Criteria
Inclusion Criteria
- R/NG servicewomen who have returned from deployment in service of and/or to Iraq/Afghanistan within the last 60 months.
Exclusion Criteria
- Any disability that would impair individuals ability to provide consent and participate in the interview.
Data sourced from ClinicalTrials.gov (NCT01710306). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.